Cancer clinical trials that use less-reliable shortcut endpoints save relatively little time, according to an analysis of 107 cancer drugs approved for 188 indications from 2006 to 2017. Image:...
Young adults undergoing toxic therapies for cancer have highly effective options to preserve fertility. But the great cost – easily $15,000 or more for a woman – puts the option out of the reach...
Exploring immune therapy combinations to stop aggressive breast cancers. Unraveling the gene changes that make juvenile myelomonocytic leukemia so difficult-to-treat. Developing a biomarker to guide...
Breast cancers that emerge after a woman gives birth are significantly more likely to spread and become life-threatening. And this elevated risk endures for at least 10 years, a new study has...
Cancer-fighting compounds that look promising in the laboratory often fail in human clinical trials. One reason: standard tumor models consist of cancer cells growing in a flat plastic dish with...
One study shows how it may be possible to stop acute myeloid leukemia by targeting a hidden population of cells that support the cancer. Another reveals how AML evolves to evade anti-cancer drugs,...
Gordon Mills, M.D., Ph.D., was fresh out of college when his first journal article appeared in 1976. He’s been quite busy since then, with a publication count that just hit quadruple...
A new series of science talks produced by the OHSU Knight Cancer Institute debuts this month in Portland. Researchers, clinicians and patients are going on stage to present interconnected stories of...
Even when anti-cancer drugs appear to eliminate tumors, a resistant few malignant cells can survive and allow cancers to resume a fatal onslaught. Researchers at OHSU in Portland have revealed a...
Developing exercise as "medicine" for cancer. Questioning guidelines for off-label use of cancer drugs. Using a common pain reliever to reduce breast cancer risks. These were some of the most...